Central dopamine function in affective illness: evidence from precursors, enzyme inhibitors, and studies of central dopamine turnover.
D000328:Adult; D000342:Affective Symptoms / Q000175:diagnosis / Q000188:drug therapy / Q000378:metabolism*; D000786:Anger / Q000187:drug effects; D001714:Bipolar Disorder / Q000175:diagnosis; D002490:Central Nervous System / Q000187:drug effects / Q000378:metabolism*; D003863:Depression / Q000175:diagnosis; D003937:Diagnosis, Differential; D004295:Dihydroxyphenylalanine / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism* / Q000627:therapeutic use; D004299:Dopamine beta-Hydroxylase / Q000037:antagonists & inhibitors; D005260:Female; D006719:Homovanillic Acid / Q000378:metabolism; D006801:Humans; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D008875:Middle Aged; D009638:Norepinephrine / Q000378:metabolism; D010848:Picolinic Acids / Q000494:pharmacology / Q000627:therapeutic use; D011339:Probenecid / Q000627:therapeutic use; D011568:Psychiatric Nursing; D011618:Psychotic Disorders / Q000175:diagnosis; D013997:Time Factors; D014443:Tyrosine / Q000378:metabolism
D008781:Methyltyrosines; D010848:Picolinic Acids; D014443:Tyrosine; D004295:Dihydroxyphenylalanine; D004299:Dopamine beta-Hydroxylase; D011339:Probenecid; D004298:Dopamine; D009638:Norepinephrine; D006719:Homovanillic Acid